290ASYNSPECTIVE INC

🇯🇵 Japonya Borsası
1358.00
JPY
Analysis Scores
Lothien Robustness Score?
26/100
Weak
Neden bu skor?
Damodaran ?
9/100
DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik)
Dalio Risk ?
60/100
Piotroski ?
2/9
Weak
Previous period ROA data missing (C1 delta-ROA); Total assets data missing → ROA cannot be calculated (C2); Önceki yıl borç/varlık verisi yok → kaldıraç azalması kontrol edilemedi (C5); Current ratio data missing (C6); current assets data missing → turnover calculation unavailable (C9)
Graham ?
Veri Yetersiz
Özkaynaklar negatif veya sıfır — Graham formülü pozitif defter değeri gerektirir
Active Metric?
2/4
Confidence?
56%
Lothien Robustness Summary
16/100
Lothien Sağlamlık: Çok Zayıf (16/100)
Temel göstergelerin çoğu olumsuz. Lothien sağlamlık skoru düşük seviyede. | Kısa Vade: Olumsuz | Uzun Vade: Olumsuz | Pozitif: 1 | Negatif: 6 | Nötr: 0
Net Zarar
Son çeyrekte -¥1.7B zarar açıklandı. Yatırımcı dikkatli olmalı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-735.3 geriledi (¥273M → -¥1.7B). Kısa vadede olumsuz sinyal.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-45.6 düştü. Uzun vadede endişe verici.
Yüksek EV/EBITDA
EV/EBITDA: 1077.5. Pahalı değerleme.
Negatif ROE
ROE: %-3.1. Şirket özsermayesini eritiyor.
Lothien Sağlamlık Skoru: 26/100
Bileşik algoritma değerlendirmesine göre şirketin finansal yapısı zayıf görünüyor.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+59.2 artabilir (-¥1.7B → -¥706M).

Data date 2026-10-30 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-30
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
252 days
Annual Volatility ?
%77.2
VaR 95% ?
%7.71
daily max loss
VaR 99% ?
%11.03
daily max loss
CVaR 95% ?
%9.78
expected loss (tail)
Max Drawdown ?
%50.2
26.05.2026 → 29.07.2026
Skewness ?
0.10
Parametrik%7.71
Historik%7.06
Cornish-Fisher%7.48
Return Distribution
Valuation
Potential?
-38.7%
ROIC ?
-9.2%
Debt Cycle?
Geç Genişleme
Balance Sheet Analysis? Q2026/6
Toplam borç: 10.7B JPY
Net nakit pozisyonunda: -5.6B JPY (borçsuz)
Borç/Özkaynak oranı düşük: 0.28x
Cari oran güçlü: 2.18x — yükümlülükler rahat karşılanıyor
Nakit ve benzerleri: 16.2B JPY
Ödenmiş sermaye: 132.9M JPY
Net işletme sermayesi pozitif: 9.7B JPY
Fiyat TRAMA-99 altında: %-7.9 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 1475.22 JPY
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %-3.1
ROE %-3.1 — negative return on equity.
Free Cash Flow Margin (TTM) %-413.4
TTM Free Cash Flow is %-413.4'i. Negative FCF — company consuming cash.
Valuation
P/B Ratio 4.82x Sector: 2.52x
PD/DD 4.82x — sector median's %91 above. Expensive book value.
Indebtedness
Current Ratio 2.18x
Current ratio 2.18x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 64.7x
Net Debt/EBITDA 64.7x — excessive leverage. Fragile debt profile.
Debt / Equity 0.28x
Low leverage — majority of assets financed by equity.
Interest Coverage 0.5x
Interest coverage 0.5x — critical level. Risk of difficulty in interest payments.
Growth
Revenue Growth (YoY) %+2.6
Revenue YoY %2.6 grew — positive but slow growth.
Net Profit Growth (YoY) %-45.6
Loss %45.6 increased — losses deepening.
Seasonality Analysis Q4 (Eki-Ara)
Historically strongest quarter: Q4 (Oct-Dec) (avg. profit -312.8M). Weakest quarter: Q1 (Jan-Mar) (avg. profit -1.3B).
Score Explanations
Lothien Robustness
26/100
Weak robustness (26/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-38.7%
Minus %38.7 expected value (833.34) vs current price comparison. 2/4 valuation models could be calculated. Model confidence %56.
Components: P/B target: 697.89 | EV/EBITDA target: 340.00
Damodaran Valuation
9/100
Very Weak
Dalio Risk Analysis
60/100
Moderate debt risk (60/100). Interest coverage ratio 0.5x — weak, fragile. Debt/EBITDA 64.7x — high debt burden.
Leverage: 43/100 | Debt Service: 56/100 | Quality: 28/100
ROIC - Return on Capital
%-9.2
ROIC (%-9.2) cost of capital (10.2%) below → destroying value.
WACC: %10.2
Debt Cycle Phase
Geç Genişleme
Piotroski F-Score
2/9
Weak Piotroski (2/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Total assets data missing → ROA cannot be calculated (C2)
Weak
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/B Ratio
4.82x vs 2.52x
Compared to sector %91 more expensive (by book value)
EV/EBITDA
1077.5x vs 10.4x
Compared to sector %10250 higher EV/EBITDA
ROIC vs WACC
%-9.2 vs %10.2 WACC
ROIC 19.3 bps below cost of capital
Net Profit Margin (TTM)
%-3.4 vs %7.0 EBITDA margin
TTM net profit margin %-3.4
TRAMA-99 Trend — Downtrend
Price (1358.00), TRAMA-99 line's %7.9 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 1358.00
TRAMA: 1475.22
Difference: %-7.9
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
290A — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.